Global travel has become easier, and humans are able to cover vast distances in a short period. In a recent publication in Science, Abel and Sander [6] quantify global international migration flows. They estimate that the largest movements occur between southern and western Asia, from Latin to North America, and within Africa. [6] The report clearly shows that there is a huge circulation of migrants among sub-Saharan African countries. This migration dwarfs the number leaving Africa, and receives no media attention. [6] SA is one of the countries in sub-Saharan Africa that is a common destination for migrants. The Western Cape and Gauteng provinces are regions of SA that are malaria non-endemic. [2] They are also popular destinations for some migrant communities.
In their retrospective observational study, Opie et al. [3] describe a number of imported cases of malaria at Groote Schuur Hospital (GSH), Cape Town. In this study a high rate of malaria was seen in Somali and Bangladeshi migrants over a 4-year period. Plasmodium falciparum was the most common malarial species identified. A mortality rate of <1% was found in this study, which is in keeping with the national target rate. Opie et al. postulate that the low mortality rate may be due to the semi-immunity of the majority of the patients, who came from malaria-endemic areas. Another possibility not mentioned in the article could be that GSH has a dedicated infectious disease department that advises on the management of all cases of malaria admitted to the hospital. It must be noted that not all folders were found and analysed, a common limitation of retrospective reviews that has the potential to underestimate the true mortality.
The increased influx of migrants from malaria-endemic countries has a significant impact on imported malaria cases. [7] The number of migrants who return to their home countries to visit friends and relatives (VFRs) has also increased. Often VFRs do not consider themselves at risk of acquiring malaria and therefore may not seek pre-travel advice on malaria prophylaxis. A common misconception among VFRs is that they have lifelong immunity to malaria. [7] Frean et al. [4] describe outbreaks of odyssean malaria over a 6-year period. They demonstrate a high complication rate and mortality due to delayed or missed diagnoses. They emphasise that malaria should always be remembered as a cause of unexplained fever and thrombocytopenia, even in the absence of a travel history.
The treatment for uncomplicated P. falciparum malaria that is currently recommended in all endemic and non-endemic provinces of SA is artemether-lumefantrine. [8] Primaquine is used for radical cure of P. vivax and P. ovale infections. [8] Severe malaria is a medical emergency that requires high-level hospital care, so when a severe case is diagnosed at a primary healthcare facility or by a private general practitioner, emergency transfer to hospital is the norm in endemic and non-endemic provinces. [8] Intravenous artesunate is the parenteral antimalarial currently recommended by the World Health Organization for the treatment of severe malaria in children and adults. [9] It is not yet registered for use in SA, but there is limited availability through a special access programme for compassionate use on a named-patient basis. [8] Patterns of migration in Africa demonstrate that the largest movement of people occurs in sub-Saharan Africa. SA in particular is a common destination for many migrant populations. Imported and odyssean malaria should be remembered as a cause of unexplained fever and thrombocytopenia. Key to reducing the complications and mortality related to malaria is early recognition and treatment.
